Vogelsang G B, Spivak J L
Am J Med. 1984 Jun;76(6):1144-50. doi: 10.1016/0002-9343(84)90872-6.
Acute nonlymphocytic leukemia developed in a 57-year-old woman following adjuvant therapy with melphalan for ovarian carcinoma. Maturation of differentiating marrow myeloid and erythroid precursors was megaloblastic. The serum vitamin B12 level was low, and Schilling test revealed vitamin B12 malabsorption correctable with intrinsic factor. Megaloblastic maturation of the marrow cells was converted to normoblastic following treatment with vitamin B12 and folic acid. However, blast cells persisted in the marrow, and cytogenetic analysis revealed aneuploidy and trisomy 18. In contrast to the marrow blast cells, there was a decline in circulating blast cells following vitamin replacement, suggesting that these cells were capable of maturation but required vitamin B12 for this purpose.
一名57岁女性在接受美法仑辅助治疗卵巢癌后发生急性非淋巴细胞白血病。分化中的骨髓髓系和红系前体细胞成熟呈巨幼样变。血清维生素B12水平低,Schilling试验显示维生素B12吸收不良,可通过内因子纠正。维生素B12和叶酸治疗后,骨髓细胞的巨幼样成熟转变为正常幼红细胞成熟。然而,原始细胞持续存在于骨髓中,细胞遗传学分析显示非整倍体和18号染色体三体。与骨髓原始细胞相反,维生素替代治疗后循环原始细胞数量下降,提示这些细胞能够成熟,但需要维生素B12才能实现。